Tsherniak A, Vazquez F, Montgomery PG, Weir BA, Kryukov G, Cowley GS, Gill S, Harrington WF, Pantel S, Krill-Burger JM, et al. Defining a Cancer Dependency Map. Cell. 2017;170:564–576 e16.
NOTES
Tsherniak, AviadVazquez, FranciscaMontgomery, Phil GWeir, Barbara AKryukov, GregoryCowley, Glenn SGill, StanleyHarrington, William FPantel, SashaKrill-Burger, John MMeyers, Robin MAli, LeviGoodale, AmyLee, YenaraeJiang, GuozhiHsiao, JessicaGerath, William F JHowell, SaraMerkel, ErinGhandi, MahmoudGarraway, Levi ARoot, David EGolub, Todd RBoehm, Jesse SHahn, William CengP01 CA203655/CA/NCI NIH HHS/U01 CA199253/CA/NCI NIH HHS/R01 CA130988/CA/NCI NIH HHS/U01 CA176058/CA/NCI NIH HHS/U54 CA112962/CA/NCI NIH HHS/Cell. 2017 Jul 27;170(3):564-576.e16. doi: 10.1016/j.cell.2017.06.010.
Abstract
Most human epithelial tumors harbor numerous alterations, making it difficult to predict which genes are required for tumor survival. To systematically identify cancer dependencies, we analyzed 501 genome-scale loss-of-function screens performed in diverse human cancer cell lines. We developed DEMETER, an analytical framework that segregates on- from off-target effects of RNAi. 769 genes were differentially required in subsets of these cell lines at a threshold of six SDs from the mean. We found predictive models for 426 dependencies (55%) by nonlinear regression modeling considering 66,646 molecular features. Many dependencies fall into a limited number of classes, and unexpectedly, in 82% of models, the top biomarkers were expression based. We demonstrated the basis behind one such predictive model linking hypermethylation of the UBB ubiquitin gene to a dependency on UBC. Together, these observations provide a foundation for a cancer dependency map that facilitates the prioritization of therapeutic targets.
Last updated on 02/17/2021